Nrxn1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
NRXN1 (Neurexin-1) is a gene encoding a cell adhesion molecule essential for synaptic formation, function, and maintenance. It is one of the largest genes in the human genome. [@graf2004]
Nrxn1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
NRXN1 (Neurexin-1) is a gene encoding a cell adhesion molecule essential for synaptic formation, function, and maintenance. It is one of the largest genes in the human genome. [@graf2004]
Overview
Mermaid diagram (expand to render)
Function
NRXN1 encodes neurexin-1, a presynaptic cell adhesion molecule that mediates synaptic contact between [neurons](/entities/neurons) and is essential for synapse formation and function.
Molecular Function
Synaptic Adhesion: Binds to neuroligins (postsynaptic) to form synaptic connections
Heterozygous deletions cause ASD in ~0.5% of cases
Disrupts synaptic connectivity
Impairs social behavior in mouse models
Often with intellectual disability
Schizophrenia
NRXN1 variants associated with schizophrenia:
Copy number variations in patients
Alters synaptic function
May contribute to cognitive deficits
Alzheimer's Disease
NRXN1 involvement in AD:
Altered expression in AD brain
Synaptic loss correlates with cognitive decline
May interact with amyloid pathology
Parkinson's Disease
NRXN1 in PD:
Regulates dopaminergic synapse function
Altered in PD models
May contribute to synaptic vulnerability
Epilepsy
NRXN1 mutations cause epilepsy:
Febrile seizures
Absence seizures
Typically with developmental delay
Therapeutic Targeting
No direct therapeutic targeting yet, but approaches include:
Gene therapy to restore NRXN1 expression
Small molecules to enhance synaptic adhesion
Cell-based therapies for NRXN1-deficient neurons
Key Publications
[Sudhof TC (2008) Neuroligins and neurexins link synaptic function to cognitive disease. Nature. PMID:18828744](https://pubmed.ncbi.nlm.nih.gov/18828744)
[Graf ER et al. (2004) Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins. Cell. PMID:15543130](https://pubmed.ncbi.nlm.nih.gov/15543130)
[Bellen HJ et al. (2010) The family of neurexin genes: search for common ground. Neuron. PMID:20720501](https://pubmed.ncbi.nlm.nih.gov/20720501)
The study of Nrxn1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
[Sudhof TC, Neuroligins and neurexins link synaptic function to cognitive disease (2008)](https://pubmed.ncbi.nlm.nih.gov/18828744/)
[Graf ER, et al, Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins (2004)](https://pubmed.ncbi.nlm.nih.gov/15543130/)
[Bellen HJ, et al, The family of neurexin genes: search for common ground (2010)](https://pubmed.ncbi.nlm.nih.gov/20720501/)
[Craig AM, Kang Y, Neurexin-neuroligin synaptic adhesion: from synaptogenesis to cognitive disease (2007)](https://pubmed.ncbi.nlm.nih.gov/17965655/)
[Reichelt AC, et al, Neurexin-1 alternative splicing is a marker of synaptic dysfunction in Alzheimer's disease (2022)](https://pubmed.ncbi.nlm.nih.gov/35228672/)
Pathway Diagram
The following diagram shows the key molecular relationships involving NRXN1 Gene discovered through SciDEX knowledge graph analysis: